Under FDA law, any potential maker of a generic version of the drugs at issue will have to wait until November 2019 at the earliest just to file an ANDA, …
Under FDA law, any potential maker of a generic version of the drugs at issue will have to wait until November 2019 at the earliest just to file an ANDA, …